Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab and Triamcinolone for Macular Edema in CRVO
NCT00566761Phase 4Terminated
- Sponsor
- Asociación para Evitar la Ceguera en México
- Start
- Jun 2007
- Primary completion
- Jun 2007
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of triamcinolone in macular edema, sponsored by Asociación para Evitar la Ceguera en México. Started Jun 2007; status: terminated.
02
Drugs
triamcinolone
03
Conditions
macular edema
Beyond the preview
Go deeper on NCT00566761.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00566761.